Xue Chao

7PUBLICATIONS
48CO-AUTHORS
Molecular targetsCancer cell biologyPredictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 18, 2026
Patient-derived xenograft models of primary breast cancer for preclinical evaluation of neoadjuvant therapies.

Stefan J Hutten, Xue Chao, Madelon Badoux

|Jun 24, 2025
The C-Terminal Kinase Domain-Binding and Suppression Motif Prevents Constitutive Activation of FGFR2.

Daniel Zingg, Chi-Chuan Lin, Julia Yemelyanenko

|Apr 30, 2025
Large-scale Characterization of Orthotopic Cell Line-Derived Xenografts Identifies TGFβ Signaling as a Key Regulator of Breast Cancer Morphology and Aggressiveness.

Catrin Lutz, Xue Chao, Bim de Klein

|Aug 29, 2023
MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer.

Jinhyuk Bhin, Julia Yemelyanenko, Xue Chao

|May 04, 2021
Clinicopathologic and genetic features of metaplastic breast cancer with osseous differentiation: a series of 6 cases.

Xue Chao, Wanlin Tan, Julia Y Tsang

|Aug 20, 2020
Immune parameters associated with survival in metaplastic breast cancer.

Xue Chao, Lili Liu, Peng Sun

Pageof 2

Frequent Collaborators

4 joint publications

Jos Jonkers

3 joint publications

Jinhyuk Bhin

3 joint publications

Catrin Lutz

3 joint publications

Marieke van de Ven